Ashish Chandra Shrestha

Contacts

Student (MAE)

Biography

Ashish Chandra Shrestha is a Master of Applied Epidemiology (MAE) scholar in the 2022-23 cohort, undertaking a placement at the Communicable Disease Branch, Queensland Health.

He holds a MSc in Microbiology and a PhD in Microbiology, Epidemiology, Public Health and Health Services.

Prior to commencing his MAE, he worked as a Senior Epidemiologist at SA Health. He has also worked as an Early Career Researcher at the University of Adelaide in vaccine development against Zika and hepatitis C.

During his PhD at the University of Queensland and the Australian Red Cross Lifeblood, he evaluated the risks posed by hepatitis E virus to the blood supply safety. He has also held lecturer positions in medical schools of Nepal, where he was teaching Medical Microbiology to medical, dentistry and nursing students.

 

Research

Research interests

  • Epidemiology
  • Microbiology
  • Virology
  • Vaccinology
  • Public Health and Health Services

Publications

  • Shrestha, A.C., Wijesundara, D.K., Masavuli, M.G., Mekonnen, Z.A., Gowans, E.J., Grubor-Bauk, B. (2019). Cytolytic perforin as an adjuvant to enhance the immunogenicity of DNA vaccines. Vaccines, 7, 38.

  • Shrestha, A.C., Flower, R.L., Seed, C.R., Keller, A.J., Hoad, V., Harley, R., Leader, R., Polkinghorne, B., Furlong, C., Faddy, H.M. (2017). Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply. Blood Transfusion, 15(3): 191–198.

  • Shrestha, A.C., Flower, R.L., Seed, C.R., Keller, A.J., Harley, R.J., Chan, H.T., Hoad, V., Warrilow, D., Holmberg, J.A., Faddy, H.M. (2017). Hepatitis E virus RNA in Australian blood donations. Transfusion, 112(7):614-621.

  • Shrestha, A.C., Flower, R.L.P., Seed, C.R., Hoad, V., Rajkarnikar, M., Shrestha, S.K., Thapa, U., Faddy, H.M. (2016). Hepatitis E virus seroepidemiology: A post-earthquake study among blood donors in Nepal. BMC Infectious Diseases, 16 (1):707.

  • Shrestha, A.C., Flower, R.L.P., Seed, C.R., Stramer, S.L., Faddy, H.M. (2016). A comparative study of assay performance of commercial hepatitis E virus enzyme-linked immunosorbent assay (ELISA) kits in Australian blood donor samples. Journal of Blood Transfusion, 2016:9647675.

  • Shrestha, A.C., Faddy, H.M., Flower, R.L.P., Seed, C.R., Keller, A. (2015). Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history? Pathology, 47(2): 97-100.

  • Shrestha, A.C., Seed, C.R., Flower, R.L.P., Rooks, K.M., Keller, A.J., Harley, R.J., Chan, H-T., Holmberg, J.A., Faddy, H.M. (2014). Hepatitis E Virus and implications for blood supply safety, Australia. Emerging Infectious Diseases, 20(11):1940-2.

  • Shrestha, A.C., Ghimire, P., Tiwari, B.R., Rajkarnikar, M. (2012). Co-infection rate of HIV, HBV and Syphilis among HCV seropositive identified blood donors in Kathmandu, Nepal. Infection Ecology and Epidemiology, 2, 10.3402/iee.v2i0.14835.

  • Shrestha, A.C., Ghimire, P., Tiwari, B.R., Rajkarnikar, M. (2009). Transfusion transmissible infections among blood donors in Kathmandu, Nepal. Journal of Infection in Developing Countries, 3(10): 797-797.